L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours

Clinical trial NCT02076620 · COMPLETED

Trial details

NCT number: NCT02076620
Sponsor: Philogen S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Amenable to Anthracycline Therapy Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy

Start date: 2013-01-16
Primary completion: 2018-01-25
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.